HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of mild hyperglycemia +/- meta-iodo-benzylguanidine on the radiation response of R3230 Ac tumors.

Abstract
The effects of glucose or meta-iodo-benzylguanidine (MIBG) on oxygen utilization (QO2) of several tumor cell lines were studied using a Clark-type electrode chamber. For in vivo studies, rats bearing R3230 Ac rat mammary adenocarcinomas were utilized. To evaluate changes in tumor oxygenation induced by glucose or MIBG, intratumoral pO2 and skeletal muscle pO2 were measured using Eppendorf Histography. To find the effect of mild hyperglycemia (i.p., 1 g/kg) +/- MIBG (i.p., 20 mg/kg) on the radiation response, a growth delay assay was used. Glucose alone produced a approximately 20% inhibition of QO2 in several tumor cells we tested except Q7 tumor cells. MIBG inhibited QO2 in R3230 Ac tumors. The median tumor pO2 for glucose + MIBG was increased from 5.3 mm Hg to 13.8 mm Hg. We hypothesized that combined treatment with glucose + MIBG significantly enhanced radiation-induced tumoricidal effects on R3230 Ac tumors, mainly due to reduction in QO2 and increase in tumor pO2.
AuthorsIntae Lee, Jerry D Glickson, Mark W Dewhirst, Dennis B Leeper, Randy Burd, Harish Poptani, Lydie Nadal, W Gillies McKenna, John E Biaglow
JournalAdvances in experimental medicine and biology (Adv Exp Med Biol) Vol. 530 Pg. 177-86 ( 2003) ISSN: 0065-2598 [Print] United States
PMID14562715 (Publication Type: Journal Article)
Chemical References
  • 3-Iodobenzylguanidine
  • Glucose
  • Oxygen
Topics
  • 3-Iodobenzylguanidine (pharmacology)
  • Adenocarcinoma (metabolism)
  • Animals
  • Female
  • Glucose (metabolism)
  • Humans
  • Hyperglycemia (physiopathology)
  • Kidney (metabolism)
  • Mammary Neoplasms, Experimental (metabolism)
  • Muscle, Skeletal (metabolism)
  • Oxygen (metabolism)
  • Rats
  • Rats, Inbred F344
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: